Superantigen antagonist peptides
The production of superantigenic exotoxins by Gram positive bacteria underlies the pathology of toxic shock syndrome. Future treatment strategies for superantigen-mediated diseases are likely to be directed at blocking the three-way interaction between superantigen, T cell receptor and major histoco...
Guardat en:
| Publicat a: | Crit Care |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2001
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137266/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11299061/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc986 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|